JP2023533041A5 - - Google Patents

Info

Publication number
JP2023533041A5
JP2023533041A5 JP2023501231A JP2023501231A JP2023533041A5 JP 2023533041 A5 JP2023533041 A5 JP 2023533041A5 JP 2023501231 A JP2023501231 A JP 2023501231A JP 2023501231 A JP2023501231 A JP 2023501231A JP 2023533041 A5 JP2023533041 A5 JP 2023533041A5
Authority
JP
Japan
Application number
JP2023501231A
Other languages
Japanese (ja)
Other versions
JP2023533041A (ja
JP7752675B2 (ja
JPWO2022007713A5 (https=
Filing date
Publication date
Priority claimed from CN202010639186.0A external-priority patent/CN111773227A/zh
Priority claimed from CN202010638926.9A external-priority patent/CN111658652A/zh
Priority claimed from CN202010994928.1A external-priority patent/CN112641789A/zh
Application filed filed Critical
Priority claimed from PCT/CN2021/104197 external-priority patent/WO2022007713A1/zh
Publication of JP2023533041A publication Critical patent/JP2023533041A/ja
Publication of JPWO2022007713A5 publication Critical patent/JPWO2022007713A5/ja
Publication of JP2023533041A5 publication Critical patent/JP2023533041A5/ja
Application granted granted Critical
Publication of JP7752675B2 publication Critical patent/JP7752675B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023501231A 2020-07-06 2021-07-02 ウイルスに対するタウロリジンの使用 Active JP7752675B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
CN202010639186.0A CN111773227A (zh) 2020-07-06 2020-07-06 牛磺罗定在制备抗新型冠状病毒SARS-CoV-2药物中的应用
CN202010639186.0 2020-07-06
CN202010638926.9A CN111658652A (zh) 2020-07-06 2020-07-06 牛磺罗定在制备抗冠状病毒药物中的应用
CN202010638926.9 2020-07-06
CN202010994928.1A CN112641789A (zh) 2020-09-21 2020-09-21 一种化合物在治疗和预防新型冠状病毒和流感病毒药物方面的应用
CN202010994928.1 2020-09-21
PCT/CN2021/104197 WO2022007713A1 (zh) 2020-07-06 2021-07-02 牛磺罗定在抗病毒中的应用

Publications (4)

Publication Number Publication Date
JP2023533041A JP2023533041A (ja) 2023-08-01
JPWO2022007713A5 JPWO2022007713A5 (https=) 2023-11-22
JP2023533041A5 true JP2023533041A5 (https=) 2023-11-22
JP7752675B2 JP7752675B2 (ja) 2025-10-10

Family

ID=77998103

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023501231A Active JP7752675B2 (ja) 2020-07-06 2021-07-02 ウイルスに対するタウロリジンの使用

Country Status (4)

Country Link
JP (1) JP7752675B2 (https=)
CN (1) CN113491700B (https=)
BR (1) BR112023000308A2 (https=)
WO (1) WO2022007713A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114917285B (zh) * 2022-04-06 2023-06-23 军事科学院军事医学研究院军事兽医研究所 一种多糖化合物在预防和治疗呼吸道病毒感染药物中的应用
CN115350181B (zh) * 2022-08-17 2023-12-29 吉林大学 一种小分子化合物在制备抗病毒感染的药物中的应用
CN117503777A (zh) * 2023-03-17 2024-02-06 中国人民解放军军事科学院军事医学研究院 化合物在抗病毒中的应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6608051B1 (en) * 1999-03-12 2003-08-19 Medpointe Healthcare Inc. Compositions and methods for treating blood
US6302108B1 (en) * 2000-03-10 2001-10-16 Carter-Wallace, Inc Spermicidal and viricidal compositions
EP2699572B1 (en) * 2011-04-21 2016-08-10 Origenis GmbH Heterocyclic compounds as kinase inhibitors
DE102011077393A1 (de) 2011-06-10 2012-12-13 Johannes Reinmüller Antiinfektives Mittel
WO2013190355A1 (en) 2012-06-18 2013-12-27 Geistlich Pharma Ag Oxathiazine derivatives as antibacterial and anticancer agents
MX392353B (es) * 2014-12-19 2025-03-24 Geistlich Pharma Ag Procedimientos para preparar compuestos de tipo oxatiazina
WO2017040655A1 (en) * 2015-08-31 2017-03-09 Cormedix Inc. Delivery of active agents using nanofiber webs
CN111773227A (zh) * 2020-07-06 2020-10-16 长春迈灵生物工程有限公司 牛磺罗定在制备抗新型冠状病毒SARS-CoV-2药物中的应用
CN112641789A (zh) * 2020-09-21 2021-04-13 军事科学院军事医学研究院军事兽医研究所 一种化合物在治疗和预防新型冠状病毒和流感病毒药物方面的应用
CN111617086A (zh) * 2020-07-06 2020-09-04 长春迈灵生物工程有限公司 牛磺罗定在制备抗hpv病毒药物中的应用
CN111658652A (zh) * 2020-07-06 2020-09-15 长春迈灵生物工程有限公司 牛磺罗定在制备抗冠状病毒药物中的应用
CN111671758A (zh) * 2020-07-06 2020-09-18 长春迈灵生物工程有限公司 牛磺罗定在制备抗hiv病毒药物中的应用

Similar Documents

Publication Publication Date Title
BR112023005462A2 (https=)
BR112023012656A2 (https=)
BR112021014123A2 (https=)
BR112023009656A2 (https=)
BR112022009896A2 (https=)
BR112021017747A2 (https=)
BR112022024743A2 (https=)
BR112022026905A2 (https=)
BR112023011738A2 (https=)
BR112023004146A2 (https=)
BR112023006729A2 (https=)
BR102021018859A2 (https=)
BR102021015500A2 (https=)
BR102021007058A2 (https=)
BR102020022030A2 (https=)
BR112023016292A2 (https=)
BR112023011539A2 (https=)
BR112023011610A2 (https=)
BR112023008976A2 (https=)
BR102021020147A2 (https=)
BR102021018926A2 (https=)
BR102021018167A2 (https=)
BR102021017576A2 (https=)
BR102021016837A2 (https=)
BR102021016551A2 (https=)